MiMedx Announces Productive Meeting With FDA
October 28, 2013 at 18:51 PM EDT
MiMedx Group (NASDAQ: MDXG ) announced today that the Company concluded a productive meeting with the Food and Drug Administration earlier today, October 28, 2013. Parker H. Petit, Chairman and CEO, said, "We were pleased to have had the opportunity to present to the FDA our basis for concluding
